Levels and values of inflammatory markers in patients with angina pectoris

Hon-Kan Yip1, Chiung-Jen Wu, Chi-Ling Hang

  • 1Division of Cardiology, Chang Gung Memorial Hospital, Kaohsiung, Taiwan, ROC.

International Heart Journal
|September 15, 2005
PubMed

Insights

High-sensitivity C-reactive protein (hs-CRP), white blood cell (WBC) count, and vascular cell adhesion molecule-1 (VCAM-1) are elevated in angina pectoris (AP) patients. hs-CRP is strongly associated with unstable AP.

Area of Science:

  • Cardiovascular Medicine
  • Inflammation Research
  • Biomarker Discovery

Background:

  • Inflammation is key in atherosclerotic plaque development.
  • C-reactive protein (CRP) drives plaque inflammation and vascular cell adhesion molecule-1 (VCAM-1) expression.
  • Limited data exists on high-sensitivity (hs)-CRP, white blood cell (WBC) count, and VCAM-1 in stable versus unstable angina pectoris (AP).

Purpose of the Study:

  • To investigate and compare levels of hs-CRP, WBC count, and VCAM-1 in patients with stable and unstable AP.
  • To determine the association of these inflammatory markers with unstable AP.

Main Methods:

  • A prospective cohort study of 128 AP patients (stable and unstable) undergoing coronary stenting.
  • Blood samples collected pre-angiography for hs-CRP, WBC count, and VCAM-1 analysis.
  • Comparison with 40 healthy volunteers.

Main Results:

  • All three markers (hs-CRP, WBC, VCAM-1) were significantly higher in AP patients than healthy volunteers (P < 0.0001).
  • hs-CRP and WBC count were significantly higher in unstable AP than stable AP (P < 0.0001).
  • VCAM-1 was higher in severe unstable AP (class II/III) but not mild unstable AP (class I) compared to stable AP.
  • hs-CRP was independently associated with unstable AP (P = 0.0002).

Conclusions:

  • Circulating hs-CRP, WBC count, and VCAM-1 are elevated in patients with angina pectoris.
  • hs-CRP is a strong independent predictor of unstable angina pectoris.

Related Concept Videos

Angina III: Clinical Manifestations and Assessment01:29

Angina III: Clinical Manifestations and Assessment

Angina manifests as chest pain, tightness, or squeezing discomfort typically located behind the breastbone. It can radiate to the neck, jaw, shoulders, and inner aspects of the upper arms, most commonly the left arm. Patients may experience shortness of breath, fatigue, profuse sweating, dizziness, indigestion, heartburn, palpitations, anxiety, and vomiting as accompanying symptoms. This pain often lasts a few minutes and is triggered by physical exertion, emotional stress, heavy meals, or cold...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Angina I: Introduction01:30

Angina I: Introduction

Definition and Symptoms: Angina (angina pectoris) is chest pain or discomfort caused by myocardial ischemia, which occurs when the heart muscle receives insufficient oxygen-rich blood. It typically manifests as pressing, squeezing, or crushing sensations in the chest and may radiate to the shoulders, arms, neck, jaw, or back.Primary Cause: In a healthy state, the coronary arteries can dilate (widen) to increase blood flow and meet the increased oxygen demand during physical activity or...
Angina II: Classification01:27

Angina II: Classification

Angina, also known as angina pectoris, is a chest pain resulting from diminished blood flow to the heart muscle and is often a symptom of coronary artery disease. Angina presents several variants with distinctive attributes, etiologies, and therapeutic approaches. The main types of angina include stable, unstable, variant (Prinzmetal's), microvascular, intractable, and silent ischemia.Stable angina is caused by atherosclerosis, which leads to the formation of plaques that narrow the coronary...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...